This Popular Weed Killer Wreaks Havoc on Animals and Is Probably Hurting Us, Too

The EPA releases a damning report about atrazine—and kicks the can to the next administration.

<a href="hhttp://www.shutterstock.com/pic-107961041/stock-photo-crop-duster-spraying-corn.html?src=YO8eMJxY2RIdppzCwvFimw-1-34">David Malik</a>/Shutterstock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Atrazine, the second most commonly used herbicide in the United States, is mainly used to control weeds in the corn blanketing much of the Midwest. The chemical also routinely turns up in streams and drinking water. And according to a new Environmental Protection Agency preliminary risk assessment, it may be doing serious harm to fish, animals, and amphibians, even at extremely low exposure levels. 

Atrazine may be doing serious harm to fish, animals, and amphibians, even at extremely low levels.

To figure out whether a toxin is damaging ecosystems, EPA scientists crunch data from peer-reviewed research to establish what they call “levels of concern”—the threshold above which the chemical can be expected to cause harm. In the areas where it is most commonly used, mainly the Midwestern corn belt, atrazine turns up in the environment at rates that exceed established levels of concern “by as much as 22, 198, and 62 times for birds, mammals, and fish, respectively,” the report concluded.

As for amphibians like frogs, the report found “potential for chronic risk” from atrazine at real-world exposure levels—not rapid death, like what a roach might experience after a blast of Raid, but long-term, subtle damage, like an impeded ability to reproduce. The EPA paper cited several studies by Tyrone Hayes, an integrative biologist at the University of California-Berkeley who has found that miniscule amounts of the chemical can trigger sex changes in frogs. In response to his research, atrazine’s maker, the agrichemical giant Syngenta, embarked on a spirited, sustained effort to discredit him, detailed in a 2012 Mother Jones piece and a 2014 New Yorker feature.

I asked Hayes whether he felt vindicated by the EPA’s new report. “Asking me if I feel vindicated is like asking someone who’s been in jail for 10 years for something he didn’t do whether he feels vindicated when he gets out,” he said.

Syngenta, for its part, rejects the concerns raised by the EPA. “The draft ecological risk assessment drew conclusions based on a number of scientific errors and flawed interpretations,” a company spokesperson wrote in an email. “This draft ecological risk assessment is inconsistent with a number of EPA’s previous conclusions as well as assessments by other regulatory agencies around the world.”

The European Union banned atrazine in 2004, citing its potential to contaminate water and harm ecosystems. And this latest EPA report suggests the US government might also consider reining in use of the chemical. But probably not anytime soon. The agency has been reviewing atrazine’s registration since 2009, and the wheels turn slowly. On Monday, the EPA published the assessment in the Federal Register, opening a 60-day period for public comment. An EPA spokeswoman says it won’t be finalized until 2017—meaning no regulatory action until well after the presidential election.

A government panel found that atrazine had “suggestive evidence of carcinogenic potential” for ovarian cancer, non-Hodgkin’s lymphoma, hairy-cell leukemia, and thyroid cancer.

Meanwhile, the EPA is also mulling an even more heated issue: atrazine’s impact on human health. The agency expects to release its human-health assessment “later in 2016,” a spokesperson said. Back in 2011, the EPA released the final deliberations by a panel of independent scientists it had convened to address the topic. Its conclusions were not comforting. (Here’s my summary from the time.) The panel found that atrazine had “suggestive evidence of carcinogenic potential” for ovarian cancer, non-Hodgkin’s lymphoma, hairy-cell leukemia, and thyroid cancer, and that “there is inadequate evidence” to determine whether atrazine causes prostate cancer, breast cancer, liver cancer, esophageal cancers, and childhood cancers.

A recent paper by Texas A&M and Iowa State University researchers looked at research published since 2000 and concluded that “higher concentrations of atrazine in drinking water” have been associated with a variety of birth defects in people.

“The science has been settled for a long time,” Hayes told me. “Now it’s politics and economics.” Apparently, it will be up to a Clinton or, gulp, Trump administration to do something about it.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate